The healthcare industry is an important core sector in Baden-Württemberg. However, the EU's new, stricter regulations are putting massive pressure on small and medium-sized companies in particular. For example, manufacturers of medical technology and diagnostic products will have to contend with drastically increased requirements for proof of clinical evidence in the future, both when launching new products and when recertifying existing products. One of the biggest hurdles is currently the lack of access to suitable patient samples and explants, i.e. implants removed from the body. These are essential if the safety and performance of medical and diagnostic products are to be demonstrated in accordance with EU regulations in the future.
To ensure that innovative healthcare products continue to be developed in Baden-Württemberg and vital medical devices remain available on the market, the "ProbenMaterialCenterBW" funding project has now been launched. The project, which is funded by the Ministry of Economics, Labor and Tourism of the state of Baden-Württemberg, has a duration of 21 months. During this period, the two consortium partners, the NMI, Natural and Medical Sciences Institute at the University of Tübingen, and the health network BioLAGO e.V., intend to jointly establish a competence network to improve the availability of clinical samples and retrieved implants for the healthcare industry. The ProbenMaterialCenterBW will for the first time provide cross-market access to relevant clinical samples and explants.Furthermore, improved access to samples will allow manufacturers to bring medical technology and diagnostic products to market more quickly in the future.